New research indicates that a newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana.
However, this substance is produced by the body's own nerve cells.
Drug Abuse
The use of Drugs for reasons other than its prescribed recommendation, is known as Drug abuse or substance abuse. Drug abuse or substance abuse is initiated by various biological and social factors.
Advertisement
William R. Marrs of the Neurobiology and Behavior program at the University of Washington (UW) and Dr. Nephi Stella, UW professor of pharmacology and psychiatry conducted the study.
The find may improve treatment in people with multiple sclerosis, Huntington's disease and other neurological disorders.
Specifically targeted treatments, for example, might give cancer and AIDS patients the same medicinal benefits as marijuana without its mind-altering properties.
![Trauma Care]( "Trauma Care")
Accident and trauma care is an important public health challenge that requires immediate attention. Injury (trauma) is the leading cause of death for all age groups under the age of 44.
Cannabinoid signalling systems use signals called endocannabinoids - chemicals that mimic the effect of marijuana.
They are common throughout the body and affect a variety of functions.
Stella's team looked at an enzyme called ABHD6 that degrades 2-AG nerve signalling substance by splitting it with water. 2-AG is an endocannabinoid that is also implicated in brain cell migration and brain tissue inflammation.
The broken down 2-AG was less effective in stimulating the microglia - the brain defenders-to get moving.
"The enzymatic steps that control the production and inactivation of endocannabinoids constitute promising molecular targets for indirectly modulating the activity of cannabinoid receptors," the authors noted.
Designing treatments that manage the production and inactivation of important enzymes like ABHD6 could thereby control such conditions as brain inflammation or overactive brain signals.
For example, blocking a specific enzyme to heighten a certain signal might ameliorate pain and also act as anti-anxiety and antidepressant therapy, the authors explained.
Drugs that reduce the activity of the ABDH6 enzyme might prevent brain damage from an overactive response to a virus.
The results were reported in the latest Nature Neuroscience.
Source: ANI
Specifically targeted treatments, for example, might give cancer and AIDS patients the same medicinal benefits as marijuana without its mind-altering properties.
Trauma Care
Accident and trauma care is an important public health challenge that requires immediate attention. Injury (trauma) is the leading cause of death for all age groups under the age of 44.
Advertisement
Cannabinoid signalling systems use signals called endocannabinoids - chemicals that mimic the effect of marijuana.
They are common throughout the body and affect a variety of functions.
Stella's team looked at an enzyme called ABHD6 that degrades 2-AG nerve signalling substance by splitting it with water. 2-AG is an endocannabinoid that is also implicated in brain cell migration and brain tissue inflammation.
The broken down 2-AG was less effective in stimulating the microglia - the brain defenders-to get moving.
"The enzymatic steps that control the production and inactivation of endocannabinoids constitute promising molecular targets for indirectly modulating the activity of cannabinoid receptors," the authors noted.
Designing treatments that manage the production and inactivation of important enzymes like ABHD6 could thereby control such conditions as brain inflammation or overactive brain signals.
For example, blocking a specific enzyme to heighten a certain signal might ameliorate pain and also act as anti-anxiety and antidepressant therapy, the authors explained.
Drugs that reduce the activity of the ABDH6 enzyme might prevent brain damage from an overactive response to a virus.
The results were reported in the latest Nature Neuroscience.
Source: ANI
Advertisement
 Drug Abuse Screening TestDrug Abuse Screening Test (DAST) is a screening test to find out if you need professional help with 'Drug Abuse' problem. This is only an anonymous self test. | Advertisement
|
Advertisement
Recommended Reading
Latest Alcohol & Drug Abuse News
Among individuals who are released from prison, opioid overdose is a leading cause of death with a risk more than ten-fold the general population.
Being recently released from prison or jail puts many at high risk of opioid overdose.
Using marijuana every day can raise a person's risk of coronary artery disease by a third compared with those who never use the drug.
Patients who are cannabis users are more often male and suffer from depression, anxiety, and schizoaffective disorders.
To help people with opioid addiction, researchers are turning to artificial intelligence to create and optimize potential new drugs.